<DOC>
	<DOCNO>NCT00003170</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Glutamine may effective treatment acute diarrhea cause radiation therapy . It known glutamine effective treatment acute diarrhea cause radiation therapy . PURPOSE : Randomized double-blinded phase III trial determine effectiveness glutamine prevent acute diarrhea patient pelvic cancer receive radiation therapy .</brief_summary>
	<brief_title>Glutamine Preventing Acute Diarrhea Patients With Pelvic Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether glutamine effective reduce acute treatment related diarrhea patient receive pelvic external beam radiation therapy adjuvant primary treatment malignancy . II . Determine whether glutamine reduce chronic treatment relate enteropathy follow completion therapy . III . Determine whether glutamine cause toxicity situation . IV . Provide initial reliability validity data patient bowel function questionnaire . OUTLINE : This randomize , double-blind , placebo control study . Patients stratify history anterior resection rectum ( yes v ) ; total plan cumulative dose , include boost field external beam radiotherapy ( 4500-5350 cGy v 5350-6000 cGy v great 6000 cGy ) ; use fluorouracil ( none v bolus vs continuous infusion ) ; primary site ( rectal cancer v prostate cancer v gynecological cancer v ) . Beginning first second day radiotherapy , patient receive either oral glutamine placebo twice daily , include day receive radiotherapy . Patients continue treatment throughout radiotherapy continue 2 week postradiotherapy grade 3 diarrhea occurs . Patients follow weekly 4 week , 12 month , 24 month radiotherapy .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm pelvic cancer Planned therapy undergo continuous definitive adjuvant external beam pelvic radiation therapy without fluorouracil ( 5FU ) plus minus levamisole No split course radiation therapy Planned course radiation therapy must also meet follow criterion : Entire pelvis must encompass plan radiotherapy field Total plan dose central axis midplane isocenter whole pelvic field must 45005350 cGy Treatment must give 45 time per week onetreatmentperday basis No stool incontinence stool frequency 7 per day prior initiation radiation therapy Must enter study second radiation therapy fraction No current prior metastases beyond pelvic regional lymph node Must function rectum No plan perineal irradiation No anal cancer No active intraluminal gastrointestinal ( GI ) tumor Patients completely resectioned GI tumor also receive adjuvant treatment eligible PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Creatinine le 2 time upper limit normal Other : No know allergy glutamine No history inflammatory bowel disease No medical condition may interfere treatment Not pregnant nursing Adequate contraception require fertile patient PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No concurrent leucovorin chemotherapy agent , except 5FU without levamisole Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior pelvic radiotherapy No brachytherapy prior completion external beam radiotherapy Surgery : No abdominalperineal resection , Hartmann procedure , surgical procedure leave patient without function rectum</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>